, Société française de recherche et médecine du sommeil. Classification internationale des pathologies du sommeil: [ICSD3] : traduite de l'International Classification of Sleep Disorders, third version, American Academy of Sleep Midicine, 2014.

, American Psychiatric Association. DSM-5, manuel diagnostique et statistique des troubles mentaux, 2015.

C. A. Espie, Insomnia: conceptual issues in the development, persistence, and treatment of sleep disorder in adults, Annu Rev Psychol, vol.53, pp.215-258, 2002.

C. A. Espie, N. M. Broomfield, K. Macmahon, L. M. Macphee, and L. M. Taylor, The attentionintention-effort pathway in the development of psychophysiologic insomnia: a theoretical review, Sleep Med Rev. août, vol.10, issue.4, pp.215-260, 2006.

A. G. Harvey, A cognitive model of insomnia, Behav Res Ther. août, vol.40, issue.8, pp.869-93, 2002.

C. M. Morin, J. Stone, D. Trinkle, J. Mercer, and S. Remsberg, Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia complaints, Psychol Aging. sept, vol.8, issue.3, pp.463-470, 1993.

D. Riemann, K. Spiegelhalder, B. Feige, U. Voderholzer, M. Berger et al., The hyperarousal model of insomnia: a review of the concept and its evidence, Sleep Med Rev. févr, vol.14, issue.1, pp.19-31, 2010.

P. Medrano-martínez and M. J. Ramos-platón, Cognitive and emotional alterations in chronic insomnia, Rev Neurol. 16 févr, vol.62, issue.4, pp.170-178, 2016.

C. M. Morin and C. A. Espie, Insomnia: a Clinical Guide to Assessment and Treatment

M. A. Boston and U. S. Springer, , 2004.

C. M. Morin, Vaincre les ennemis du sommeil. Montréal: Éditions de l'Homme, 2009.

M. Jansson-fröjmark and S. J. Linton, The role of psychological mechanisms to insomnia in its early phase: a focus on arousal, distress, and sleep-related beliefs, Psychol Health, vol.23, issue.6, pp.691-705, 2008.

M. Jansson and S. J. Linton, Psychological mechanisms in the maintenance of insomnia: arousal, distress, and sleep-related beliefs, Behav Res Ther. mars, vol.45, issue.3, pp.511-532, 2007.

A. Norell-clarke, M. Jansson-fröjmark, M. Tillfors, A. G. Harvey, and S. J. Linton, Cognitive processes and their association with persistence and remission of insomnia: findings from a longitudinal study in the general population, Behav Res Ther. mars, vol.54, pp.38-48, 2014.

M. M. Ohayon and C. F. Reynolds, Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD), Sleep Med, vol.10, issue.9, pp.952-60, 2009.

C. Chan-chee, V. Bayon, J. Bloch, F. Beck, J. Giordanella et al., Epidemiology of insomnia in France, Rev Epidemiol Sante Publique. déc, vol.59, issue.6, pp.409-431, 2011.

D. Leger, C. Guilleminault, J. P. Dreyfus, C. Delahaye, and M. Paillard, Prevalence of insomnia in a survey of 12,778 adults in France, J Sleep Res. mars, vol.9, issue.1, pp.35-42, 2000.

M. Leblanc, C. Mérette, J. Savard, H. Ivers, L. Baillargeon et al., Incidence and Risk Factors of Insomnia in a Population-Based Sample, Sleep. 1 août, vol.32, issue.8, pp.1027-1064, 2009.

F. C. Blais, C. M. Morin, A. Boisclair, V. Grenier, B. Guay et al., Prevalence and treatment of patients in general practice, Can Fam Physician Med Fam Can. avr, vol.47, pp.759-67, 2001.

T. Roth, S. Jaeger, J. R. Kalsekar, A. Stang, P. E. Kessler et al., Sleep Problems, Comorbid Mental Disorders, and Role Functioning in the National Comorbidity Survey Replication

, Biol Psychiatry. 15 déc, vol.60, issue.12, pp.1364-71, 2006.

D. Riemann, C. Baglioni, C. Bassetti, B. Bjorvatn, L. D. Groselj et al., European guideline for the diagnosis and treatment of insomnia, J Sleep Res, vol.26, issue.6, pp.675-700

R. Heinzer, J. Haba-rubio, and M. Tafti, HypnoLaus sleep cohort study, Rev Med Suisse, vol.7, issue.315, pp.2140-2141, 2011.

F. Beck, J. Richard, and D. Léger, Prévalence et facteurs sociodémographiques associés à l'insomnie et au temps de sommeil en France (15-85ans), Rev Neurol (Paris). 1 déc, vol.169, issue.12, pp.956-64, 2013.

M. Jansson-fröjmark and S. J. Linton, The Course of Insomnia over One Year: a Longitudinal Study in the General Population in Sweden, Sleep. 1 juin, vol.31, issue.6, pp.881-887, 2008.

D. Léger, F. Allaert, and M. Massuel,

, Presse Medicale Paris Fr, vol.34, pp.1358-62, 1983.

M. M. Ohayon, Epidemiology of insomnia: what we know and what we still need to learn, Sleep Med Rev. avr, vol.6, issue.2, pp.97-111, 2002.

F. Sofi, F. Cesari, A. Casini, C. Macchi, R. Abbate et al., Insomnia and risk of cardiovascular disease: a meta-analysis, Eur J Prev Cardiol. janv, vol.21, issue.1, pp.57-64, 2014.

A. N. Vgontzas, D. Liao, E. O. Bixler, G. P. Chrousos, and A. Vela-bueno, Insomnia with objective short sleep duration is associated with a high risk for hypertension, Sleep. avr, vol.32, issue.4, pp.491-498, 2009.

M. Nano, P. Fonseca, R. Vullings, and R. M. Aarts, Measures of cardiovascular autonomic activity in insomnia disorder: A systematic review, PloS One, vol.12, issue.10, p.186716, 2017.

F. P. Cappuccio and M. A. Miller, Sleep and Cardio-Metabolic Disease, Disponible sur, vol.19, 2017.

C. Baglioni, G. Battagliese, B. Feige, K. Spiegelhalder, C. Nissen et al., Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies, J Affect Disord. déc, vol.135, issue.1-3, pp.10-19, 2011.

S. Fulda and H. Schulz, Cognitive dysfunction in sleep disorders, Sleep Med Rev. déc, vol.5, issue.6, pp.423-468, 2001.

, Société française de recherche et médecine du sommeil. Classification internationale des pathologies du sommeil: [ICSD3] : traduite de l'International Classification of Sleep Disorders, third version, American Academy of Sleep Midicine, 2014.

, American Psychiatric Association. DSM-5, manuel diagnostique et statistique des troubles mentaux, 2015.

C. A. Espie, Insomnia: conceptual issues in the development, persistence, and treatment of sleep disorder in adults, Annu Rev Psychol, vol.53, pp.215-258, 2002.

C. M. Morin, J. Stone, D. Trinkle, J. Mercer, and S. Remsberg, Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia complaints, Psychol Aging. sept, vol.8, issue.3, pp.463-470, 1993.

C. M. Morin and C. A. Espie, Insomnia: a Clinical Guide to Assessment and Treatment

M. A. Boston and U. S. Springer, , 2004.

M. Jansson and S. J. Linton, Psychological mechanisms in the maintenance of insomnia: arousal, distress, and sleep-related beliefs, Behav Res Ther. mars, vol.45, issue.3, pp.511-532, 2007.

F. Beck, J. Richard, and D. Léger, Prévalence et facteurs sociodémographiques associés à l'insomnie et au temps de sommeil en France (15-85ans), Rev Neurol (Paris). 1 déc, vol.169, issue.12, pp.956-64, 2013.

D. Léger, F. Allaert, and M. Massuel, Attitude toward insomnia: survey of 6043 French general practitioners, Presse Medicale Paris Fr, vol.34, pp.1358-62, 1983.

D. Léger, C. Guilleminault, G. Bader, E. Lévy, and M. Paillard, Medical and socio-professional impact of insomnia, Sleep. 15 sept, vol.25, issue.6, pp.625-634, 2002.

C. M. Morin, L. Bélanger, M. Leblanc, H. Ivers, J. Savard et al., The Natural History of Insomnia: A Population-Based 3-Year Longitudinal Study, Arch Intern Med. 9 mars, vol.169, issue.5, pp.447-53, 2009.

, AFSSAPS Etat des lieux de la consommation des benzodiazépines en France Janvier, 2012.

A. Palmaro, J. Dupouy, and M. Lapeyre-mestre, Benzodiazepines and risk of death: Results from two large cohort studies in France and UK, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol, vol.25, issue.10, pp.1566-77, 2015.

. Rivotril--ansm, Agence nationale de sécurité du médicament et des produits de santé

D. Sur,

, Commission de la transparence Avis du 5 juillet, HAS, 2017.

N. Authier, M. Becchio, D. Haro, L. Magnin, C. Mallaret et al., Compte-rendu de la scéance du 19 juin, 2014.

, Prise en charge du patient adulte se plaignant d'insomnie en médecine générale, Médecine Sommeil. déc, vol.4, issue.14, pp.5-27, 2007.

, Réévaluation du Service Médical Rendu des benzodiazépines hypnotiques et apparentés. Commission de la transparence, HAS, 2014.

, Quelle place pour les benzodiazépines dans l'insomnie ? HAS Bon usage du médicamment, HAS, 2017.

, Etat des lieux de la consommation des benzodiazépines -Point d'Information -ANSM : Agence nationale de sécurité du médicament et des produits de santé

D. Sur, ANSM:Etat des lieux de la consommation des benzodiazepines en France Avril, p.60, 2017.

M. Billiard and Y. Dauvilliers, Les Troubles du Sommeil (2e Édition), 2011.

E. K. Stranks and S. F. Crowe, The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis, J Clin Exp Neuropsychol, vol.36, issue.7, pp.691-700, 2014.

S. M. Park, J. Ryu, D. R. Lee, D. Shin, J. M. Yun et al., Zolpidem use and risk of fractures: a systematic review and meta-analysis, Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA, vol.27, issue.10, pp.2935-2979, 2016.

J. Macfarlane, C. M. Morin, and J. Montplaisir, Hypnotics in insomnia: the experience of zolpidem, Clin Ther, vol.36, issue.11, pp.1676-701, 2014.

C. Victorri-vigneau, M. Gérardin, M. Rousselet, M. Guerlais, M. Grall-bronnec et al., An update on zolpidem abuse and dependence, J Addict Dis, vol.33, issue.1, pp.15-23, 2014.

N. Authier, M. Bonnet, J. Delile, C. Haro-l,-magnin, and M. Mallaret, Compterendu de la séance du 21 novembre, p.16, 2013.

G. Hajak, W. E. Müller, H. U. Wittchen, D. Pittrow, and W. Kirch, Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data, Addiction, vol.98, issue.10, pp.1371-1379, 2003.

I. A. Liappas, P. N. Malitas, N. P. Dimopoulos, O. E. Gitsa, A. I. Liappas et al., Zolpidem dependence case series: possible neurobiological mechanisms and clinical management, J Psychopharmacol Oxf Engl. mars, vol.17, issue.1, pp.131-136, 2003.

M. Rousselet, F. Feuillet, M. Gerardin, P. Jolliet, J. Hardouin et al., The French addictovigilance network clinical assessment: Z-drugs, true false twins, Expert Opin Drug Saf. sept, vol.16, issue.9, pp.1063-1072, 2017.

C. Yen, Y. , C. Ko, C. Hwang, T. Chen et al., Correlates of dependence and beliefs about the use of hypnotics among zolpidem and zopiclone users, Subst Use Misuse. févr, vol.50, issue.3, pp.350-357, 2015.

, Zolpidem : nouvelles conditions de prescription et de délivrance depuis le 10 avril -Communications -Ordre National des Pharmaciens

, Arrêté du 7 janvier 2017 portant application d'une partie de la réglementation des stupéfiants aux médicaments à base de zolpidem administrés par voie orale | Legifrance

D. Sur,

, Pays basque : des ordonnances falsifiées en famille

. Sudouest and . Fr,

D. Sur,

, Quelle place pour les benzodiazépines dans l'insomnie ? Fiche BUM, HAS, 2017.

C. M. Morin, J. P. Culbert, and S. M. Schwartz, Nonpharmacological interventions for insomnia: a metaanalysis of treatment efficacy, Am J Psychiatry. août, vol.151, issue.8, pp.1172-80, 1994.

C. M. Morin and R. Benca, Chronic insomnia, Lancet Lond Engl. 24 mars, vol.379, issue.9821, pp.1129-1170, 2012.

M. T. Smith, M. L. Perlis, A. Park, M. S. Smith, J. Pennington et al., Comparative metaanalysis of pharmacotherapy and behavior therapy for persistent insomnia, Am J Psychiatry. janv, vol.159, issue.1, pp.5-11, 2002.

C. M. Morin, C. Bastien, B. Guay, M. Radouco-thomas, J. Leblanc et al., Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia, Am J Psychiatry. févr, vol.161, issue.2, pp.332-374, 2004.

, Développement de la prescription de thérapeutiques non médicamenteuses validées, HAS, 2017.

, CNAM. circulaire cir-4/2019, 2018.